CRUK fellow and group leader. Interested in extracellular matrix, sugars, and immunity.
London
Joined July 2013
- Tweets111
- Following152
- Followers226
- Likes166
Oliver Pearce retweeted
I am delighted to open a PhD position at @QMULBartsTheLon in collaboration with @OliverMPearce @pearce_lab Please apply if you are interested in #ECM #digitalpathology #multiplex #earlydiagnosis
Oliver Pearce retweeted
Postdoc to join our lab as part of our Wellcome Discovery Award team with @LabWithers and @ClatworthyLab
Apply below! (closing date May 10th)
ucl.ac.uk/work-at-ucl/search…
If you are an informatics PhD or MSc/MRes level researcher looking to work on the tumour microenvironment, ECM, and immunity, please get in touch. We will be advertising shortly....
Oliver Pearce retweeted
🔊 EARLY REGISTRATION DEADLINE: 15 APRIL 🔊
#ECM2024 is fast approaching, and we invite you to register today: ecm-congress.org/registratio…
@IntSocMatBio @amsocmatbio @DSMB_dk @BSMB1 @FinnSocMatBio @SFBMEc @Matrixbiologie @MBIreland @MatrixBioANZ @SwissMatrixBio
Oliver Pearce retweeted
3/3 Both studies identify factors in the TME that help explain clinical outcomes.
So, can we target these factors to overcome barriers to therapy response?
Yes! We're working on it and hope to share more information in the future!
Oliver Pearce retweeted
2/3 In addition to composition, ECM mechanics are also capable of regulating cell phenotypes, as shown in Liu et al
onlinelibrary.wiley.com/doi/…
Oliver Pearce retweeted
1/3 We are delighted to announce two new publications from our lab exploring ECM and cell phenotype!
@PriyankaHirani5 | @YingLiu2005 | @OliverMPearce | @QMBCI
In Hirani et al, we identified ECM molecules that can support or inhibit T-cell trafficking
aacrjournals.org/cancerresco…
Oliver Pearce retweeted
2/2 Here’s our team at this years CRH awards ceremony! From left to right @DrEllyTyler co-founder & Post-Doc, @Katie__Thornton technician, and our newest recruit! @m_burgerramos co-founder & PhD student, @OliverMPearce co-founder & team leader, @LudoTarantola PhD student
Oliver Pearce retweeted
1/2 It was a great pleasure for us to join the 2024 @CR_Horizons innovations and entrepreneurship awards, nominated in two categories, Further Faster Together to @OliverMPearce, and Early Career Entrepreneur to @m_burgerramos
#IEAwards24
Oliver Pearce retweeted
Interested in #macrophage biology in cancer?
Join us for our @MacEdiUni annual symposium and hear from @OliverMPearce from @QMBCI about how #macrophages interact with & are educated by extracellular matrix. @EdinUni_IRR
Registration & details 👉 ed.ac.uk/inflammation-resear…
We are delighted that Prof. Sonia Garel will join us in June for our @MacEdiUni annual symposium to discuss the role of #microglia in brain development.
Registration and full details 👉 ed.ac.uk/inflammation-resear…
@EdinUni_IRR @britsocimm @socmucimm @edin_EID @EdinUniBrainSci
Oliver Pearce retweeted
Delighted to share my PhD work recently published in @CRC_AACR showing how VCAN and CS associate with immune exclusion in TNBC. aacrjournals.org/cancerresco…
@Barts_Charity @againstbc @QMBCI @OliverMPearce @UProteoglycans @pearce_lab
Oliver Pearce retweeted
We're hiring! Come and help immuno-oncology companies break down barriers to success!
jobs.ac.uk/job/DBW438/resear…
Oliver Pearce retweeted
👩🏫Our students recently came together for BCI #postgrad day to celebrate their progress and showcase their work to peers and colleagues from across the institute @QMULBartsTheLon
The whole day was organised for students by students, thanks to the hard work of our @BciPhdForum.
Incredible bacterial vectors from our partner and friend @PedroCSampaio
@OliverMPearce holding court at the #CRUKAllFellows. Pointing out the importance of the extracellular matrix and immunotherapy... and some incredible bacterial vectors to target tumour ECM. Also - a great example of commercialisation via @CR_Horizons. Awesome stuff (PP)
Oliver Pearce retweeted
Check out our preprint on the role of sialic acid and Siglecs on myeloid-derived suppressor cells.
#glycotime #Immunotherapy
Engagement of sialylated glycans with Siglec receptors on myeloid suppressor cells inhibit anti-cancer immunity via CCL2 biorxiv.org/content/10.1101/…
Oliver Pearce retweeted
Honoured and proud to receive the #ForWomenInScience L'Oreal-UNESCO award! Thank you @FondationLOreal @unesco for supporting us!
Oliver Pearce retweeted
Two more weeks to apply for a post-doc position in my lab at @QMBCI to investigate mechanisms of genome stability at the replication fork ! jobs.ac.uk/job/CZT658/postdo…
get in touch and apply !
Oliver Pearce retweeted
Less than 2 weeks to apply for this PhD position in my lab! bartscancer.london/about/vac…
Application is now open for this PhD position in my lab, funded by @Barts_Charity for 4 years. findaphd.com/phds/project/ta…. UK tuition fee rate applicants only.
Oliver Pearce retweeted
Two weeks left to apply for a 3-years post-doc position in my lab. get in touch if interested and apply !
jobs.ac.uk/job/CZT658/postdo…
Oliver Pearce retweeted
This is a great opportunity for scientists to transition to #biotech #industry while still collaborating with academia! Don't miss the chance. Few more days to apply. #Immunotherapy #Cancer
Looking for a #postdoc between academia and company? Come to work with us @QMBCI and @liftbiosciences to develop new cell therapies for #Cancer patients. Amazing opportunity UKRI funded for scientists looking to transition to companies. Please
RT. qmul.ac.uk/jobs/vacancies/it…